{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:41:16Z","timestamp":1760096476488,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004101","name":"Lady Tata Memorial Trust, India","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004101","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.biopha.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T18:52:48Z","timestamp":1434739968000},"page":"160-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Preclinical model for identification of therapeutic targets for CML offers clues for handling imatinib resistance"],"prefix":"10.1016","volume":"73","author":[{"given":"Poonam R.","family":"Molli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhura B.","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind D.","family":"Ingle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishigandha R.","family":"Naik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2015.06.004_bib0310","first-page":"85","article-title":"Chromosome studies on normal and leukemic human leukocytes","volume":"25","author":"Nowell","year":"1960","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.biopha.2015.06.004_bib0315","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/1097-0320(20001215)42:6<379::AID-CYTO1005>3.0.CO;2-Q","article-title":"Actin polymerization in response to different chemoattractants is reduced in granulocytes from chronic myeloid leukemia patients","volume":"42","author":"Radhika","year":"2000","journal-title":"Cytometry"},{"key":"10.1016\/j.biopha.2015.06.004_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-4598-11-16","article-title":"RhoA: a therapeutic target for chronic myeloid leukemia","volume":"11","author":"Molli","year":"2012","journal-title":"Mol Cancer."},{"key":"10.1016\/j.biopha.2015.06.004_bib0325","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/j.1460-2075.1993.tb05928.x","article-title":"Conserved transducer coupling but different effector linkage upon expression of the myeloid fMet-Leu-Phe receptor in insulin secreting cells","volume":"12","author":"Lang","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2015.06.004_bib0330","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.06.004_bib0335","first-page":"942","article-title":"Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources","volume":"19","author":"Chomczynski","year":"1995","journal-title":"Biotechniques"},{"key":"10.1016\/j.biopha.2015.06.004_bib0340","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1073\/pnas.85.15.5698","article-title":"Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources","volume":"85","author":"Kawasaki","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.biopha.2015.06.004_bib0345","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1073\/pnas.74.12.5463","article-title":"DNA sequencing with chain-terminating inhibitors","volume":"74","author":"Sanger","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.biopha.2015.06.004_bib0350","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1083\/jcb.66.1.188","article-title":"Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining","volume":"66","author":"Krishan","year":"1975","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0355","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000129818","article-title":"An air-drying method for meiotic preparations from mammalian testes","volume":"15","author":"Evans","year":"1964","journal-title":"Cytogenetics"},{"key":"10.1016\/j.biopha.2015.06.004_bib0360","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1126\/science.472759","article-title":"Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils","volume":"205","author":"Niedel","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.biopha.2015.06.004_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-2697(89)90191-7","article-title":"Viability measurements in mammalian cell systems","volume":"179","author":"Cook","year":"1989","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2015.06.004_bib0370","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0171-2985(98)80079-X","article-title":"Expression of maturation-\/migration-related molecules on human dendritic cells from blood and skin","volume":"198","author":"Ebner","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.biopha.2015.06.004_bib0375","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0955-0674(96)80050-0","article-title":"Signal transduction and actin filament organization","volume":"8","author":"Zigmond","year":"1996","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0380","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0145-2126(89)90002-7","article-title":"PMN cells from chronic myeloid leukemia (CML) patients show defective chemotaxis in remission","volume":"13","author":"Naik","year":"1989","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0385","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0145-2126(92)90142-T","article-title":"Fluid pinocytosis and esterase-oxidase in chronic myeloid leukemic granulocytes are differentially stimulated by chemotactic peptide","volume":"16","author":"Naik","year":"1992","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0390","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/0145-2126(90)90183-A","article-title":"Flow cytometric studies on actin polymerization in PMN cells from chronic myeloid leukemia (CML) patients","volume":"14","author":"Naik","year":"1990","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0395","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1096-8652(199607)52:3<155::AID-AJH4>3.0.CO;2-S","article-title":"Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants","volume":"52","author":"Radhika","year":"1996","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0400","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1038\/sj.onc.1206626","article-title":"Differential interaction and activation of Rho family GTPases by p210bcr-abl and p190bcr-abl","volume":"22","author":"Harnois","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0405","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1038\/sj.onc.1203621","article-title":"Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b","volume":"19","author":"Schnelzer","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0410","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1158\/1078-0432.CCR-08-1486","article-title":"Toward a cure for chronic myeloid leukemia","volume":"14","author":"O\u2019Hare","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0415","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1158\/1078-0432.CCR-08-0117","article-title":"Therapeutic options against BCR-ABL1 T315I-positive chronic myelogenous leukemia","volume":"14","author":"Quintas-Cardama","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0420","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0145-2126(00)00070-9","article-title":"Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research","volume":"24","author":"Drexler","year":"2000","journal-title":"Leuk. Res."},{"key":"10.1016\/j.biopha.2015.06.004_bib0425","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.biopha.2015.06.004_bib0430","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0301-472X(99)00130-7","article-title":"Abl kinase but not PI3-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells","volume":"28","author":"Gaston","year":"2000","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0435","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1128\/MCB.15.3.1286","article-title":"The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation","volume":"15","author":"Renshaw","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0440","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1182\/blood.V80.7.1788.1788","article-title":"Clonal evolution in a myeloid cell line transformed to interleukin-3 independent growth by retroviral transduction and expression of p210bcr\/abl","volume":"80","author":"Laneuville","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.06.004_bib0445","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.1073\/pnas.92.21.9540","article-title":"Signaling by ABL oncogenes through cyclin D1","volume":"92","author":"Afar","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.biopha.2015.06.004_bib0450","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1101\/gad.11.18.2295","article-title":"Rho GTPases and signaling networks","volume":"11","author":"Van Aelst","year":"1997","journal-title":"Genes Dev."},{"key":"10.1016\/j.biopha.2015.06.004_bib0455","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/MCB.17.3.1324","article-title":"Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways","volume":"17","author":"Westwick","year":"1997","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0460","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:BREA.0000018422.02237.f9","article-title":"Altered Rho GTPase signaling pathways in breast cancer cells","volume":"84","author":"Burbelo","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2015.06.004_bib0465","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.7652575","article-title":"An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1","volume":"269","author":"Olson","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.biopha.2015.06.004_bib0470","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1074\/jbc.272.1.13","article-title":"Geranylgeranylated rho small GTPase(s) are essential for the degradation of p27Kip1 and facilitate the progression from G1 to S phase in growth-stimulated rat FRTL-5 cells","volume":"272","author":"Hirai","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.06.004_bib0475","first-page":"4466","article-title":"The jun and fos protein families are both required for cell cycle progression in fibroblasts","volume":"11","author":"Kovary","year":"1991","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0480","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1083\/jcb.149.4.775","article-title":"Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition","volume":"149","author":"Zondag","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0485","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-1119(02)00426-2","article-title":"The role of Rho GTPases in disease development","volume":"286","author":"Boettner","year":"2002","journal-title":"Gene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0490","first-page":"121","article-title":"Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation","volume":"1705","author":"Benitah","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2015.06.004_bib0495","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/bies.20238","article-title":"Rho GTPase expression in tumourigenesis: evidence for a significant link","volume":"27","author":"Gomez del Pulgar","year":"2005","journal-title":"Bioessays"},{"key":"10.1016\/j.biopha.2015.06.004_bib0500","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/bjc.1998.23","article-title":"Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas","volume":"77","author":"Suwa","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2015.06.004_bib0505","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/35020106","article-title":"Genomic analysis of metastasis reveals an essential role for RhoC","volume":"406","author":"Clark","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2015.06.004_bib0510","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/375338a0","article-title":"A role for Rac in Tiam1-induced membrane ruffling and invasion","volume":"375","author":"Michiels","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2015.06.004_bib0515","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/37656","article-title":"Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K","volume":"390","author":"Keely","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2015.06.004_bib0520","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1074\/jbc.M410598200","article-title":"Global effects of BCR\/ABL and TEL\/PDGFRbeta expression on the proteome and phosphoproteome: identification of the Rho pathway as a target of BCR\/ABL","volume":"280","author":"Unwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.06.004_bib0525","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccr.2011.07.016","article-title":"Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABL","volume":"20","author":"Mali","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2015.06.004_bib0530","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1038\/sj.onc.1210841","article-title":"The RhoGEF domain of p210 Bcr-Abl activates RhoA and is required for transformation","volume":"27","author":"Sahay","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0535","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1038\/sj.onc.1205678","article-title":"p38 MAPK-mediated activation of NF-kappaB by the RhoGEF domain of Bcr","volume":"21","author":"Korus","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0540","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ccr.2007.10.015","article-title":"Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease","volume":"12","author":"Thomas","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2015.06.004_bib0545","doi-asserted-by":"crossref","first-page":"27145","DOI":"10.1074\/jbc.M103565200","article-title":"Leukemia-associated Rho guanine nucleotide exchange factor, a Dbl family protein found mutated in leukemia, causes transformation by activation of RhoA","volume":"276","author":"Reuther","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2015.06.004_bib0550","first-page":"1081","article-title":"Evaluation of expression of CD15 and sCD15 in non-small cell lung cancer","volume":"15","author":"Kadota","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0555","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1172\/JCI119520","article-title":"BCR\/ABL induces multiple abnormalities of cytoskeletal function","volume":"100","author":"Salgia","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2015.06.004_bib0560","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1182\/blood.V87.10.4276.bloodjournal87104276","article-title":"Differential regulation of leukocyte function-associated antigen-1\/intercellular adhesion molecules-1-dependent adhesion and aggregation in HL-60 cells","volume":"87","author":"Katagiri","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2015.06.004_bib0565","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/j.1460-2075.1993.tb05797.x","article-title":"An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias","volume":"12","author":"McWhirter","year":"1993","journal-title":"Embo J."},{"key":"10.1016\/j.biopha.2015.06.004_bib0570","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1083\/jcb.124.3.325","article-title":"The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity","volume":"124","author":"Van Etten","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0575","first-page":"1149","article-title":"creased tyrosine phosphorylation of focal adhesion proteins in myeloid cell lines expressing p210BCR\/ABL, J.D. Griffin","volume":"11","author":"Salgia","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2015.06.004_bib0580","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0960-9822(02)70711-2","article-title":"Rho: theme and variations","volume":"6","author":"Ridley","year":"1996","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0585","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4049\/jimmunol.144.3.1062","article-title":"Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes","volume":"144","author":"Van Epps","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2015.06.004_bib0590","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/382177a0","article-title":"Regulation of receptor-mediated endocytosis by Rho and Rac","volume":"382","author":"Lamaze","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2015.06.004_bib0595","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2003.08.035","article-title":"Rho GTPases: potential candidates for anticancer therapy","volume":"206","author":"Aznar","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2015.06.004_bib0600","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1042\/BST0351347","article-title":"Characterization of cancer stem cells in chronic myeloid leukaemia","volume":"35","author":"Jorgensen","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2015.06.004_bib0605","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/sj.leu.2404762","article-title":"The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells","volume":"21","author":"Burthem","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.biopha.2015.06.004_bib0610","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2174\/187152908786786241","article-title":"Rho-signaling pathways in chronic myelogenous leukemia","volume":"8","author":"Kuzelova","year":"2008","journal-title":"Cardiovasc. Hematol. Disord. Drug Targets"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332215001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:58:42Z","timestamp":1760093922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332215001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":61,"alternative-id":["S0753332215001377"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2015.06.004","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical model for identification of therapeutic targets for CML offers clues for handling imatinib resistance","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}